期刊文献+

小剂量糖皮质激素对脓毒症患者血清CPR、PCT水平的影响 被引量:11

Influence of Small Doses of Glucocorticoids on Serum Levels of CPR and PCT in Sepsis Patients
下载PDF
导出
摘要 目的:探讨小剂量糖皮质激素对脓毒症血清C-反应蛋白(CRP)、血清降钙素原(PCT)水平及预后的影响。方法:选取严重脓毒症患者47例,随机分为小剂量糖皮质激素治疗组及对照组,治疗组在对照组基础上加用氢化泼尼松1 mg/(kg·d),24 h静脉泵入7 d;观察2组患者治疗前、治疗后第6、24、48 h、第3、5、7天的血清CRP、PCT浓度,并比较2组患者平均动脉压(MAP)、治疗前后急性生理和慢性健康评分(APACHEⅡ)、多器官功能不全综合征(MODS)发生率及住ICU时间。结果:治疗组在治疗后第24、48 h、第3天及第7天血清CRP较对照组低,第5天时更明显(P<0.05,P<0.01);治疗组在治疗后第6、24、48 h血清PCT较对照组低(P<0.05),第3、5、7天时更明显(P<0.05,P<0.01);治疗后6 h时MAP较对照组提高(P<0.05),APACHEⅡ评分较对照组改善明显(P<0.05),MODS发生率低于对照组(P<0.05),两组患者住ICU时间比较,差异无统计学意义(P>0.05)。结论:小剂量糖皮质激素治疗能够降低脓毒症患者血清CRP、PCT浓度,能较早逆转休克,改善患者APACHEⅡ评分及MDOS发生率,但在治疗时间上并未显示其优势。 Objective: To investigate the effect of low doses of glucocorticoid on serum C-reactive protein (CRP) and serum procalcitonin (PCT) in sepsis patients. Methods: Forty-seven patients with severe sepsis were selected and divided into low dose glucocorticoid treatment group and control group randomly. The serum CRP and PCT levels were observed before treatment, and 6 h, 24 h, 48 h, 3 and 5 days after treatment. The mean arterial pressure ( MAP), acute physiology and chronic health e- valuation (APACHE Ⅱ ), incidence of multiple organ dysfunction syndrome (MODS) and the stay time in ICU between the two groups were compared. Results: In 24 h, 48 h, 3 and 5 days after treat- ment, the treatment group's serum levels of CRP were lower than those of control group (P 〈0.05 ), and the lowest point of serum CRP level appeared on the fifth day (P 〈 0.01 ). In 6 h, 24 h and 48 h after treatment, the treatment group's serum PCT levels were lower than those of control group (P 〈 0.05), and they were specially lower in 3, 5, and 7 days after treatment (P 〈 0.01 ). In treatment group, MAP in 6 h after treatment was higher ( P 〈 0.05 ), the APACHE II score improved more ( P 〈 0.05), and MODS incidence was lower than those in control group (P 〈 0.05), but two groups 's stay time in ICU showed no statistical difference ( P 〉 0.05 ). Conclusions: Therapy with low doses of glu-cocorticoid can reduce serum CRP and PCT levels of sepsis patients, prove APACHE Ⅱscore and reduce incidence of MDOS, but it shows ment time. reverse shock state earlier, im- no advantage in reducing treat-
出处 《贵阳医学院学报》 CAS 2015年第2期166-169,共4页 Journal of Guiyang Medical College
关键词 糖皮质激素 脓毒症 C-反应蛋白 前降钙素原 glucocorticoid sepsis C-reactive protein procalcitonin
  • 相关文献

参考文献13

二级参考文献24

  • 1张寒钰,谢苗荣.脓毒症时细胞凋亡的研究进展[J].中国急救复苏与灾害医学杂志,2007,2(5):314-317. 被引量:3
  • 2战晓芃,石耀辉,孙秀珍,陈国俊.急性心肌梗死发病与入院时C-反应蛋白水平的关系[J].中国急救医学,2001,21(1):20-21. 被引量:3
  • 3林哲绚,罗文鸿,李慧.血管内皮损伤危险因素研究进展[J].汕头大学医学院学报,2005,18(1):53-56. 被引量:12
  • 4Oberholzer A, Oberholzer C, Moldawer LL. Sepsis syndromes: understanding the role of innate and acquired immunity. Shock, 2001,16 :83.
  • 5Annane D, Bellissant E, Bollaert PE, et al. Corticosteroids for severe sepsis and septic shock: a systematic review and meta-a- nalysis. BMJ, 2004,329:480.
  • 6Sprung CL, Annane D, Keh D, et al. Hydrocortisone therapy for patients with septic shock. N Engl J Med, 2008,358:111.
  • 7Dellinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med, 20118,34:17.
  • 8Das UN. Insulin and the critically ill. Crit Care, 2002,6:262.
  • 9Gando S, Saitoh D, Ogura H, et al. Natural history of dissemi- nated intravascular coagulation diagnosed based on the newly es- tablished diagnostic criteria for critically ill patients: results of a multicenter, prospective survey. Crit Care Med, 2008,36: 145.
  • 10Zarychanski R, Doucette S, Fergusson D, et al. Early intravenous unfractionated heparin and mortality in septic shock. Crit Care Med, 2008,36:2973.

共引文献95

同被引文献76

引证文献11

二级引证文献51

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部